<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="review-article" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">DRJ</journal-id>
<journal-title>Dental Research Journal</journal-title>
<issn pub-type="ppub">1735-3327</issn>
<issn pub-type="epub">2008-0255</issn>
<publisher>
<publisher-name>Medknow Publications &#x0026; Media Pvt Ltd</publisher-name>
<publisher-loc>India</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">DRJ-9-516</article-id>
<article-categories>
<subj-group subj-group-type="headings">
<subject>Review Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Management of peri-implantitis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Prathapachandran</surname>
<given-names>Jayachandran</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="corresp" rid="cor1"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Suresh</surname>
<given-names>Neethu</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label>Department of Periodontics, Amrita School of Dentistry, Amrita Institute of Medical Sciences, Ponekkara, PO Kochi, Kerala, India</aff>
<author-notes>
<corresp id="cor1">
<bold>Address for correspondence:</bold> Dr. Jayachandran Prathapachandran, Department of Periodontics, Amrita School of Dentistry, Amrita Institute of Medical Sciences, Ponekkara, PO Kochi - 682 041, Kerala, India. E-mail: <email xlink:href="jayachandranp@aims.amrita.edu">jayachandranp@aims.amrita.edu</email>
</corresp>
</author-notes>
<pub-date pub-type="ppub">
<season>Sep&#x2013;Oct</season>
<year>2012</year>
</pub-date>
<volume>9</volume>
<issue>5</issue>
<fpage>516</fpage>
<lpage>521</lpage>
<history>
<date date-type="received"><month>01</month><year>2012</year></date>
<date date-type="accepted"><month>03</month><year>2012</year></date>
</history>
<permissions>
<copyright-statement>Copyright: &#x000a9; Dental Research Journal</copyright-statement>
<copyright-year>2012</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
</license>
</permissions>
<abstract>
<p>Peri-implantitis is a site-specific infectious disease that causes an inflammatory process in soft tissues, and bone loss around an osseointegrated implant in function. The etiology of the implant infection is conditioned by the status of the tissue surrounding the implant, implant design, degree of roughness, external morphology, and excessive mechanical load. The microorganisms most commonly associated with implant failure are spirochetes and mobile forms of Gram-negative anaerobes, unless the origin is the result of simple mechanical overload. Diagnosis is based on changes of color in the gingiva, bleeding and probing depth of peri-implant pockets, suppuration, X-ray, and gradual loss of bone height around the tooth. Treatment will differ depending upon whether it is a case of peri-implant mucositis or peri-implantitis. The management of implant infection should be focused on the control of infection, the detoxification of the implant surface, and regeneration of the alveolar bone. This review article deals with the various treatment options in the management of peri-implantitis. The article also gives a brief description of the etiopathogenesis, clinical features, and diagnosis of peri-implantitis.</p>
</abstract>
<kwd-group>
<kwd>Dental implant</kwd>
<kwd>peri-implantitis</kwd>
<kwd>peri-implant mucositis</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-1" sec-type="intro">
<title>INTRODUCTION</title>
<p>The name peri-implant disease refers to the pathological inflammatory changes that take place in the tissue surrounding a load-bearing implant.[<xref ref-type="bibr" rid="ref1">1</xref>] Two entities are described within the concept of peri-implant disease: peri-implant mucositis and peri-implantitis. Peri-implant mucositis is defined as a reversible inflammatory reaction in the soft tissues surrounding an implant.[<xref ref-type="bibr" rid="ref2">2</xref>] Peri-implantitis is an inflammatory reaction with loss of supporting bone in the tissues surrounding an implant.[<xref ref-type="bibr" rid="ref3">3</xref>] The overall frequency of peri-implantitis was reported to be 5&#x0025; to 8&#x0025; for selected implant systems.[<xref ref-type="bibr" rid="ref4">4</xref>] An increasing number of studies suggests that anaerobic plaque bacteria may have an adverse effect on peri-implant tissue health leading to peri-implantitis.[<xref ref-type="bibr" rid="ref5">5</xref>] Peri-implantis can also be directly is related to inadequate distribution of the chewing pressure on the tissues surrounding the implant, thus leading to loosening of the artificial supports, infection of the surrounding tissues, and consequently inflammatory processes.[<xref ref-type="bibr" rid="ref6">6</xref>] Failure of a dental implant is often related to failure in osseointegration. A dental implant is considered to be a failure if it is lost, mobile, or shows peri-implant bone loss of greater than 1.0 mm in the first year and greater than 0.2 mm a year after. Peri-implantitis can result in bone loss around the implant and eventual loss of the implant. The optimal result of peri-implantitis treatment is regeneration of the lost implant supporting hard and soft tissues.[<xref ref-type="bibr" rid="ref7">7</xref>]</p>
<p>Bacterial infections play the most important role in the failure of dental implants. Bacterial flora, which are associated with periodontitis and peri-implantitis, are found to be similar.[<xref ref-type="bibr" rid="ref8">8</xref>] The microorganisms most commonly related to the failure of an implant are the Gram-negative anaerobes, like <italic>Prevotella intermedia, Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans, Bacterioides forsythus, Treponema denticola, Prevotella nigrescens, Peptostreptococcus micros</italic>, and <italic>Fusobacterium nucleatum</italic>.[<xref ref-type="bibr" rid="ref8">8</xref><xref ref-type="bibr" rid="ref9">9</xref>] Healthy peri-implant tissue plays an important role as a biological barrier to some of the agents that cause peri-implant disease, and if that is destroyed, bacterial contamination spreads directly to the bone, leading to its rapid destruction. Excessive mechanical stress, poor design of the implant, and the corrosion that can occur when a non-noble metal structure is connected to a titanium implant are important factors in the onset and development of peri-implantitis. Other etiological factors include diabetes mellitus, osteoporosis, smoking, long-term treatment with corticoids, radiation, and chemotherapy.</p>
<p>The following signs and symptoms are typical for peri-implantitis lesions: radiological evidence for vertical destruction of the crestal bone. The defect is usually saucer shaped and there is osseointegration of the apical part of the fixture; vertical bone destruction associated with the formation of a peri-implant pocket; bleeding and suppuration on probing; possible swelling of the peri-implant tissues, and hyperplasia. Pain is an unusual feature, which, if present, is usually associated with an acute infection. The diagnosis of peri-implantitis needs careful differentiation from peri-implant mucositis, primary failures to achieve tissue integration, and problems lacking an inflammatory component. The diagnostic parameters used for assessing peri-implantitis include clinical indices, peri-implant probing using a rigid plastic probe, bleeding on probing (BOP), suppuration, mobility, peri-implant radiography, and microbiology.</p>
</sec>
<sec id="sec1-2">
<title>MANAGEMENT MODALITIES OF PERI-IMPLANTITIS</title>
<p>In light of the aforementioned evidence and given the continuously increasing number of implants placed in everyday clinical practice, it is reasonable to anticipate an increasing prevalence of peri-implantitis, which underlines the necessity for a predictable therapy. Peri-imlantitis and its causes is still poorly understood.[<xref ref-type="bibr" rid="ref1">1</xref>] The decision process for peri-implantitis maintenance and treatment should be a rational and evidence-based approach.[<xref ref-type="bibr" rid="ref10">10</xref>]</p>
<p>The oral microflora seems to be a defining factor for the success or the failure of a dental implant. As soon as an implant surface is exposed to the oral cavity, it becomes immediately covered by a protein layer &#x2013; the salivary pellicle &#x2013; and is colonized by oral microorganisms, forming a microbial biofilm Therapeutic strategies proposed for managing peri-implant diseases appear to be largely based on either the evidence available for treating periodontitis or on clinical empirical values but not on particular scientific findings. Surface debridements constitute the basic element for treating both periodontitis and peri-implantitis. However, the screw-shaped design of the implants, combined with various surface modifications of titanium, may facilitate plaque accumulation, resulting in bacterial biofilm formation. Mechanical debridement on such surfaces may have a limited effect and can certainly not result in the complete removal of all adhering microorganisms. Therefore, adjunctive peri-implant therapies, such as antibiotics, antiseptics, and ultrasonic and laser treatments, have been proposed to improve the non-surgical treatment options of peri-implant mucositis and peri-implantitis. Regenerative procedures using a bone graft substitute in combination with a membrane have been proposed to treat bone defects in advanced cases of peri-implantitis.</p>
<sec id="sec2-1">
<title>Local debridement</title>
<p>The implant should be cleaned by instruments softer than titanium, such as polishing with a rubber cup and paste, floss, interdental brushes, or using plastic scaling instruments. These have been shown not to roughen the implant surface unlike metal and ultrasonic scalers.[<xref ref-type="bibr" rid="ref11">11</xref>] Although implant surface damage can almost be prevented by using either ultrasonic scalers with a nonmetallic tip or resin/carbon fiber curettes, the presence of implant threads and/or implant surface roughness may compromise the access for cleaning.[<xref ref-type="bibr" rid="ref12">12</xref>]</p>
<p>The study by Karring <italic>et al</italic>.[<xref ref-type="bibr" rid="ref13">13</xref>] demonstrated that sub-mucosal debridement alone, accomplished by utilizing either an ultrasonic device or carbon fiber curettes, is not sufficient for the decontamination of the surfaces of implants with peri-implant pockets &#8805; 5 mm and exposed implant threads. So it seems reasonable to suggest that mechanical or ultrasonic debridement alone may not be an adequate modality for the resolution of peri-implantitis.</p>
</sec>
<sec id="sec2-2">
<title>Implant surface decontamination</title>
<p>Four implant surface decontamination methods were compared in a monkey model: (1) air-powder abrasive technique followed by citric acid application, (2) air-powder abrasive technique, (3) gauze soaked in saline followed by citric acid application, and (4) gauze soaked alternately in 0.1&#x0025; chlorhexidine and saline.[<xref ref-type="bibr" rid="ref14">14</xref>] Clinical parameters, radiography (including quantitative digital subtraction radiography), histology, and stereology did not reveal significant differences between any of the methods used. Findings from an <italic>in vitro</italic> study combining photosensitization by toludine blue solution and soft laser irradiation have indicated that elimination of bacteria from different titanium surfaces without modification of the implant surface was possible.[<xref ref-type="bibr" rid="ref15">15</xref>]</p>
<p>Photodynamic therapy is a non-invasive method that could be used to reduce microorganisms in peri-implantitis.[<xref ref-type="bibr" rid="ref16">16</xref>] 2&#x0025; chlorhexidine or 3&#x0025; hydrogen peroxide can be used as topical antiseptics. Decontamination of affected implants with titanium plasma-sprayed or sandblasted/acid-etched surfaces may most easily and effectively be achieved by applying gauze soaked alternately in chlorhexidine and saline.[<xref ref-type="bibr" rid="ref12">12</xref>]</p>
<p>The non-surgical treatment of peri-implantitis lesions using an erbium-doped:yttrium, aluminum, and garnet (Er:YAG) laser showed lower counts of <italic>F. nucleatum</italic> 1 month after therapy.[<xref ref-type="bibr" rid="ref17">17</xref>] According to Schwarz <italic>et al</italic>.,[<xref ref-type="bibr" rid="ref18">18</xref>] the Er:YAG laser and the combination of mechanical debridement/chlorhexidine are equally efficacious at 6 months after therapy in significantly improving peri-implant probing pocket depth and clinical attachment level, but the use of the Er:YAG laser provides a significantly higher reduction of bleeding on probing compared with the adjunctive application of chlorhexidine. However, in a subsequent study by Schwarz <italic>et al</italic>.,[<xref ref-type="bibr" rid="ref19">19</xref>] the efficacy of the Er:YAG laser appeared to be limited to a 6-month period, particularly for advanced peri-implantitis lesions. It was further suggested that a single course of treatment with the Er:YAG laser may not be adequate for achieving a stable therapy of peri-implantitis and that additional therapeutic measures, such as supplementary use of the Er:YAG laser and/or subsequent osseous regenerative procedures, might be required.</p>
</sec>
<sec id="sec2-3">
<title>Anti-infective therapy</title>
<p>Specific microbial information regarding the presence of putative pathogens is indispensible to make a meaningful decision regarding systemic or local antibiotic therapy. Although the composition of the subgingival microbial component is important for the choice of the drug, oral distribution patterns of potential pathogens are also important in deciding whether an antimicrobial agent should be administered locally or systemically. To accomplish this task, clinician needs to look at the periodontal condition of the residual teeth.</p>
<p>The study by Schwarz <italic>et al</italic>.[<xref ref-type="bibr" rid="ref18">18</xref>] demonstrated that the treatment of peri-implant infection by mechanical debridement with plastic curettes combined with antiseptic (0.2&#x0025; chlorhexidine) therapy may lead to statistically significant improvements in bleeding on probing, peri-implant probing pocket depth, and clinical attachment level at 6 months compared with baseline. A study by Renvert <italic>et al</italic>.[<xref ref-type="bibr" rid="ref20">20</xref>] showed that the addition of antiseptic therapy to mechanical debridement does not provide adjunctive benefits in shallow peri-implant lesions where the mean probing pocket depth was &#060;4 mm. Thus, it seems that the addition of antiseptic therapy to mechanical debridement does not provide adjunctive benefits in shallow peri-implant lesions with mean pocket probing depth &#060;4 mm but seems to provide additional clinical improvements in deep peri-implant lesions with mean pocket probing depth &#062;5 mm.</p>
<p>Patients suffering from localized peri-implant problems in the absence of other infections may be candidates for treatment by local drug-delivery devices. Local application of antibiotics by the insertion of tetracycline fibers for 10 days[<xref ref-type="bibr" rid="ref5">5</xref>] can provide a sustained high dose of the antimicrobial agent precisely into the affected site for several days. The use of minoccline microspheres as an adjunct to mechanical therapy is beneficial in the treatment of peri-implant lesions, but the treatment may have to be repeated.[<xref ref-type="bibr" rid="ref21">21</xref>] The study by Renvert <italic>et al</italic>.[<xref ref-type="bibr" rid="ref20">20</xref>] demonstrated that the adjunctive benefits derived from the addition of an antibiotic minocycline to mechanical debridement tend to be greater, although to a limited extent, than those achieved by the combined use of an antiseptic (chlorhexidine) and mechanical debridement. The improvements in peri-implant probing depths obtained by the adjunctive use of minocycline can be maintained during a short-term period of 12 months. In the study by Renvert <italic>et al</italic>.,[<xref ref-type="bibr" rid="ref20">20</xref>] the exhibited bone loss was not more than three implant threads.</p>
<p>If the problem is generalized, specific microbiological information is collected and antibiotics are administered systemically. Lang <italic>et al</italic>.[<xref ref-type="bibr" rid="ref5">5</xref>] suggest the following antibiotic regimes: systemic ornidazole 500 mg bd for 10 days or metronidazole 250 mg td for 10 days or a once daily combination of metronidazole 500 mg and amoxicillin 375 mg for 10 days. If peri-implantitis is associated with persisting periodontal disease, then both conditions need to be treated. In this case, the adjunctive use of systemic antibiotics may be considered. There are no clinical trials available nowadays on the systemic administration of antibiotics for the therapy of peri-implantitis.</p>
<p>Provided that mechanical and antiseptic protocols are followed prior to administering antibiotic therapy, it appears that shallow peri-implant infection may be successfully controlled using antibioics.[<xref ref-type="bibr" rid="ref1">1</xref>] But it is still open to question whether deeper peri-implant lesions can be adequately treated non-surgically by a combination of a local antibiotic and mechanical debridement.</p>
</sec>
<sec id="sec2-4">
<title>Surgical technique</title>
<p>Surgical resection is generally confined to implants placed in non-aesthetic sites.[<xref ref-type="bibr" rid="ref22">22</xref>] Surgical flap helps in comprehensive debridement and decontamination of the affected implant. Surgical therapy was carried out, using: (1) autogenous bone grafts covered by membranes, (2) autogenous bone grafts alone, (3) membranes alone, and (4) a control access flap procedure showed that defects treated with membrane-covered autogenous bone demonstrated significantly larger amounts of bone regeneration and reosseointegration than those treated with the other three procedures.[<xref ref-type="bibr" rid="ref12">12</xref>] However, membrane exposure is a frequent complication after such procedures. Exposure of porous e-PTFE membranes may result in bacterial penetration and lead to infection.[<xref ref-type="bibr" rid="ref23">23</xref>]</p>
<p>To date, no randomized controlled clinical trials are available on the use of access flap surgery (open-flap debridement) alone for the therapy of periimplantitis. A randomized comparative clinical trial by Romeo <italic>et al</italic>.[<xref ref-type="bibr" rid="ref24">24</xref><xref ref-type="bibr" rid="ref25">25</xref>] concluded that resective surgical procedures coupled with implantoplasty could have a positive influence on the survival rates of rough-surfaced implants affected by peri-implantitis as well as on peri-implant clinical parameters, such as pocket-probing depth, suppuration, and sulcus bleeding. The study by Schwarz <italic>et al</italic>.[<xref ref-type="bibr" rid="ref26">26</xref>] demonstrated that both nanocrystalline hydroxyapatite and guided bone regeneration provided clinically significant improvements in clinical parameters following 6 months of non-submerged healing. The 2-year results by Schwarz <italic>et al</italic>.[<xref ref-type="bibr" rid="ref27">27</xref>] of the same clinical study once more demonstrated that both treatment modalities were efficacious in providing clinically significant reductions of pocket-probing depth and gains in clinical attachment level, but the application of the combination of natural bone mineral and collagen membrane seemed to correlate with greater improvements in those clinical parameters and, hence, was associated with a more predictable and enhanced healing outcome. Unfortunately, the relatively small sample size of the study (22 patients) did not allow a reliable statistical comparison of the efficacy of the two therapeutic procedures. In general, more data on various regenerative techniques for treating peri-implantitis have to be accumulated.</p>
</sec>
<sec id="sec2-5">
<title>Explantation</title>
<p>If there is advanced bone loss and the implant cannot be saved, it has to be removed. If a decision has been made to remove the implant, explantation trephines are available to suit the implant system concerned. It should be noted that these trephines have an external diameter of up to 1.5 mm greater than the diameter of the implant to be removed. Thus, explantation may be associated with significant bone removal including buccal or lingual bone cortices, and damage to adjacent natural teeth where the inter-radicular space is limited. An alternative approach is to allow progressive bone loss from peri-implantitis to occur, resulting in sufficient bone loss to allow for the removal of the implant with extraction forceps. Implants may be removed by forceps when there is less than 3 to 4 mm of residual bone support.</p>
</sec>
</sec>
<sec id="sec1-3" sec-type="discussion">
<title>DISCUSSION</title>
<p>Owing to the fact that the frequency of late implant failures is relatively low, the number of longitudinal studies evaluating different treatment protocols for peri-implantitis is limited. Furthermore, ethical considerations often disallow the incorporation of proper placebo control in such trials. The treatment protocol will differ depending on whether it is peri-implant mucositis or peri-implantitis. If there is no bone loss, i.e. in the case of mucositis, bacterial plaque and calculi should be removed and chemical plaque control is achieved with 0.12&#x0025; chlorhexidine applied topically, every 8-12 h for 15 days; the patient must give oral hygiene instructions. Prosthetic design should also be checked and modified if necessary, in order to correct design defects that impede proper hygiene, as well as to correct biomechanical stress factors involved. Once this initial phase is completed, periodic check-up must be scheduled, gradually reducing the interval between maintenance visits.[<xref ref-type="bibr" rid="ref28">28</xref>]</p>
<p>If peri-implantitis is diagnosed, treatment will depend on the amount of bone lost and the esthetic impact of the implant in question. If bone loss is at an incipient stage, treatment will be identical to that prescribed for peri-imlpant mucositis, with the addition of decontamination of the prosthetic abutments and antibiotics. If bone loss is advanced or persists despite initial treatment, it will be necessary to surgically debride the soft, peri-implant tissues affected by the chronic infection, decontaminate the microimplant surface, and finally apply bone regeneration techniques aimed at recovering the lost bone.</p>
<p>Until now, no methodology has been established as a gold standard approach for the treatment of peri-implantitis. So the therapy of peri-implantitis comprises (a) the nonsurgical phase, which includes debridement by mechanical means, ultrasonic, or laser devices, either alone or combined with antiseptic and/or antibiotic agents and (b) the surgical phase, utilizing either resective or regenerative techniques.</p>
<p>The available randomized controlled and/or comparative clinical trials on peri-implantitis treatment are limited in number and have short follow-up periods and small sample sizes, thereby exhibiting a high risk of bias. It is still dubious which therapeutic strategies are the most efficacious for the treatment of peri-implantitis lesions according to their morphology, extent, and severity. However, this does not suggest that currently implemented treatment modalities may not provide beneficial outcomes in clinical practice.</p>
<p>Despite the less than adequate level of existing evidence, certain data tend to indicate the following. Sub-mucosal debridement alone may not be adequate for the removal of bacterial load from the surfaces of implants with peri-implant pockets &#8805;5 mm.[<xref ref-type="bibr" rid="ref13">13</xref>] The use of the Er:YAG laser can improve peri-implant clinical parameters within 6 months, but it remains unclear whether these effects can be maintained over time.[<xref ref-type="bibr" rid="ref19">19</xref>] The combination of minocycline and mechanical debridement appears to provide an improved treatment outcome, although to a limited extent, compared with the combination of chlorhexidine and mechanical debridement, at least during a short-term period of 12 months.[<xref ref-type="bibr" rid="ref20">20</xref>] Guided bone regeneration or the application of a bone substitute (nanocrystalline hydroxyapatite) can be efficacious for the treatment of peri-implantitis lesions.[<xref ref-type="bibr" rid="ref26">26</xref>]</p>
<p>Only long-term clinical randomized controlled trials can give a definitive answer as to the best way of dealing with failing implants.</p>
<p>Long-term success of an implant depends on regular maintenance program. During maintenance phase, peri-implant tissue should be evaluated for inflammation. Radiographs will give the status of bone around implants. These programs help in the long-term success of an implant.</p>
</sec>
<sec id="sec1-4" sec-type="conclusion">
<title>CONCLUSION</title>
<p>Prognosis of the affected implant will be contingent upon early detection and treatment of peri-implant mucositis and peri-implantitis. Even though the studies dealing with different treatment modalities of peri-implantitis are not comparable, an overall picture of some clinical improvement emerges with the use of anti-infective therapies, in terms of resolution of inflammation and bone healing. This observation, coupled with our knowledge of the indisputable role of periodontal pathogens in the etiology of peri-implantitis, indicates that some form of anti-infective therapy must be coupled with any other strategy for dealing with this problem.</p>
</sec>
</body>
<back>
<ref-list>
<title>REFERENCES</title>
<ref id="ref1">
<label>1</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mombelli</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>NP</given-names>
</name>
</person-group>
<article-title>The diagnosis and treatment of peri-implantitis.</article-title>
<source>Periodontol 2000</source>
<year>1998</year>
<volume>17</volume>
<fpage>63</fpage>
<lpage>76</lpage>
</nlm-citation>
</ref>
<ref id="ref2">
<label>2</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jovanovic</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>The management of peri-implant breakdown around functioning osseointegrated dental implants</article-title>
<source>J Periodontol</source>
<year>1993</year>
<volume>64</volume>
<fpage>1176</fpage>
<lpage>83</lpage>
</nlm-citation>
</ref>
<ref id="ref3">
<label>3</label>
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Albrektsson</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Isidor</surname>
<given-names>F</given-names>
</name>
</person-group>
<person-group person-group-type="editor">
<name>
<surname>Lang</surname>
<given-names>NP</given-names>
</name>
<name>
<surname>Karring</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Consensus report of session IV</article-title>
<source>Proceedings of the first European Workshop on Periodontology</source>
<year>1994</year>
<publisher-loc>London</publisher-loc>
<publisher-name>Quintessence</publisher-name>
<fpage>365</fpage>
<lpage>9</lpage>
</nlm-citation>
</ref>
<ref id="ref4">
<label>4</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berglundh</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Persson</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Klinge</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>A systematic review of the incidence of biological and technical complications in implant dentistry reported in prospective longitudinal studies of at least 5 years</article-title>
<source>J Clin Periodontol</source>
<year>2002</year>
<volume>29</volume>
<issue>Suppl 3</issue>
<fpage>197</fpage>
<lpage>212</lpage>
</nlm-citation>
</ref>
<ref id="ref5">
<label>5</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lang</surname>
<given-names>NP</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Corbet</surname>
<given-names>EF</given-names>
</name>
</person-group>
<article-title>Biological complications with dental implants: Their prevention, diagnosis and treatment</article-title>
<source>Clin Oral Implants Res</source>
<year>2000</year>
<volume>11</volume>
<issue>Suppl 1</issue>
<fpage>146</fpage>
<lpage>55</lpage>
</nlm-citation>
</ref>
<ref id="ref6">
<label>6</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Georgiev</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Method of treatment of periimplantitis</article-title>
<source>Journal of IMAB &#x2013; Annual Proceeding (Scientific Papers)</source>
<year>2009</year>
<comment>book 2</comment>
</nlm-citation>
</ref>
<ref id="ref7">
<label>7</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smiler</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Soltan</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The bone-grafting decision tree: A systematic methodology for achieving new bone</article-title>
<source>Implant Dent</source>
<year>2006</year>
<volume>15</volume>
<fpage>122</fpage>
<lpage>8</lpage>
</nlm-citation>
</ref>
<ref id="ref8">
<label>8</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heydenrijk</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Meijer</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Van der Reijden</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Raghoebar</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Vissink</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Stegenga</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Microbiota around root-form endosseous implants: A review of the literature</article-title>
<source>Int J Oral Maxillofac Implants</source>
<year>2002</year>
<volume>17</volume>
<fpage>829</fpage>
<lpage>38</lpage>
</nlm-citation>
</ref>
<ref id="ref9">
<label>9</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shibli</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Compagnoni</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Moreira</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Marcantonio</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Microbiologic and radiographic an&#225;lisis of ligature-induced peri-implantitis with different dental implant surfaces</article-title>
<source>Int J Oral Maxillofac Implants</source>
<year>2003</year>
<volume>18</volume>
<fpage>383</fpage>
<lpage>90</lpage>
</nlm-citation>
</ref>
<ref id="ref10">
<label>10</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abrahamsson</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Berglundh</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Wennstr&#246;mm</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lindhe</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>The periimplant hard and soft tissue characteristics at different implant systems. A comparative study in the dog</article-title>
<source>Clin Oral Implants Res</source>
<year>1996</year>
<volume>7</volume>
<fpage>212</fpage>
<lpage>9</lpage>
</nlm-citation>
</ref>
<ref id="ref11">
<label>11</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matarasso</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Quaremba</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Coraggio</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Vaia</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Cafiero</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>NP</given-names>
</name>
</person-group>
<article-title>Maintenance of implants: An <italic>in vitro</italic> study of titanium implant surface modifications subsequent to the application of different prophylaxis procedures</article-title>
<source>Clin Oral Implants Res</source>
<year>1996</year>
<volume>7</volume>
<fpage>64</fpage>
<lpage>72</lpage>
</nlm-citation>
</ref>
<ref id="ref12">
<label>12</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schou</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Berglundh</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>NP</given-names>
</name>
</person-group>
<article-title>Surgical treatment of peri-implantitis</article-title>
<source>Int J Oral Maxillofac Implants</source>
<year>2004</year>
<volume>19</volume>
<issue>Suppl</issue>
<fpage>140</fpage>
<lpage>9</lpage>
</nlm-citation>
</ref>
<ref id="ref13">
<label>13</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karring</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Stavropoulos</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ellegaard</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Karring</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Treatment of periimplantitis by the Vectors system.A pilot study</article-title>
<source>Clin Oral Implants Res</source>
<year>2005</year>
<volume>16</volume>
<fpage>288</fpage>
<lpage>93</lpage>
</nlm-citation>
</ref>
<ref id="ref14">
<label>14</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schou</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Holmstrup</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Jorgensen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Skovgaard</surname>
<given-names>LT</given-names>
</name>
<name>
<surname>Stoltze</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hjorting-Hansen</surname>
<given-names>E</given-names>
</name>
<etal/>
</person-group>
<article-title>Implant surface preparation in the surgical treatment of experimental peri-implantitis with autogenous bone graft and ePTFE membrane in cynomolgus monkeys</article-title>
<source>Clin Oral Implants Res</source>
<year>2003</year>
<volume>14</volume>
<fpage>412</fpage>
<lpage>22</lpage>
</nlm-citation>
</ref>
<ref id="ref15">
<label>15</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haas</surname>
<given-names>R</given-names>
</name>
<name>
<surname>D&#246;rtbudak</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Mensdorff-Pouilly</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Mailath</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Elimination of bacteria on different implant surfaces through photosensitization and soft laser. An <italic>in vitro</italic> study</article-title>
<source>Clin Oral Implants Res</source>
<year>1997</year>
<volume>8</volume>
<fpage>249</fpage>
<lpage>54</lpage>
</nlm-citation>
</ref>
<ref id="ref16">
<label>16</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ricardo</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Ney</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Marco</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Jonathan</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Carlos</surname>
<given-names>A</given-names>
</name>
<name>
<surname>A&#233;cio</surname>
<given-names>MY</given-names>
</name>
<etal/>
</person-group>
<article-title>Comparative Study Between the Effects of Photodynamic Therapy and ConventionalTherapy on Microbial Reduction in Ligature-Induced Peri-Implantitis in Dogs</article-title>
<source>J Periodontol</source>
<year>2005</year>
<volume>76</volume>
<fpage>1275</fpage>
<lpage>81</lpage>
</nlm-citation>
</ref>
<ref id="ref17">
<label>17</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rutger</surname>
<given-names>GP</given-names>
</name>
<name>
<surname>Ann-Marie</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Christel</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Stefan</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Microbiologic Results After Non-Surgical Erbium-Doped:Yttrium, Aluminum, and Garnet Laser or Air-AbrasiveTreatment of Peri- Implantitis: A Randomized Clinical Trial</article-title>
<source>J Periodontol</source>
<year>2011</year>
<volume>82</volume>
<fpage>1267</fpage>
<lpage>78</lpage>
</nlm-citation>
</ref>
<ref id="ref18">
<label>18</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwarz</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Sculean</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bieling</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ferrari</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Rothamel</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Becker</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Two year clinical results following treatment of peri-implantitis lesions using a nanocristalline hydroxyapatite or a natural bone mineral in combination with a collagen membrane</article-title>
<source>J Clin Periodontol</source>
<year>2008</year>
<volume>35</volume>
<fpage>80</fpage>
<lpage>7</lpage>
</nlm-citation>
</ref>
<ref id="ref19">
<label>19</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwarz</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Bieling</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bonsmann</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Latz</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Becker</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Nonsurgical treatment of moderate and advanced peri-implantitis lesions: A controlled clinical study</article-title>
<source>Clin Oral Invest</source>
<year>2006</year>
<volume>10</volume>
<fpage>279</fpage>
<lpage>88</lpage>
</nlm-citation>
</ref>
<ref id="ref20">
<label>20</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Renvert</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lessem</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dahlen</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Renvert</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lindahl</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Mechanical and repeated antimicrobial therapy using a local drug delivery system in the treatment of peri implantitis: A randomized clinical trial</article-title>
<source>J Periodontol</source>
<year>2008</year>
<volume>79</volume>
<fpage>836</fpage>
<lpage>44</lpage>
</nlm-citation>
</ref>
<ref id="ref21">
<label>21</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Renvert</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lessem</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dahl&#233;n</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Lindahl</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Svensson</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Topical minocycline microspheres versus topical chlorhexidine gel as an adjunct to mechanical debridment of incipient peri-implant infections: A randomizedclinical trial</article-title>
<source>J Clin Periodontol</source>
<year>2006</year>
<volume>33</volume>
<fpage>362</fpage>
<lpage>9</lpage>
</nlm-citation>
</ref>
<ref id="ref22">
<label>22</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Darby</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Dental implants: Maintenance, care and treatment of peri-implant infection</article-title>
<source>Aust Dent J</source>
<year>2003</year>
<volume>48</volume>
<fpage>212</fpage>
<lpage>20</lpage>
</nlm-citation>
</ref>
<ref id="ref23">
<label>23</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nowzari</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Slots</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Microbiologic and clinical study of polytetrafluoroethylene membranes for guided bone regeneration around implants</article-title>
<source>Int J Oral Maxillofac Implants</source>
<year>1995</year>
<volume>10</volume>
<fpage>67</fpage>
<lpage>73</lpage>
</nlm-citation>
</ref>
<ref id="ref24">
<label>24</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Romeo</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ghisolfi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Murgolo</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Chiapasco</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lops</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Vogel</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Therapy of peri-implantitis with resective surgery. A 3-year clinical trial on rough screw-shaped oral implants. Part I: Clinical outcome</article-title>
<source>Clin Oral Implants Res</source>
<year>2005</year>
<volume>16</volume>
<fpage>9</fpage>
<lpage>18</lpage>
</nlm-citation>
</ref>
<ref id="ref25">
<label>25</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Romeo</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lops</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Chiapasco</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ghisolfi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vogel</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Therapy of peri-implantitis with resective surgery. A 3-year clinical trial on rough screw-shaped oral implants. Part II: Radiographic outcome</article-title>
<source>Clin Oral Implants Res</source>
<year>2007</year>
<volume>18</volume>
<fpage>179</fpage>
<lpage>87</lpage>
</nlm-citation>
</ref>
<ref id="ref26">
<label>26</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwarz</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Bieling</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Latz</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nuesry</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Becker</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Healing of intrabony peri-implantitis defects following application of a nanocrystalline hydroxyapatite (Ostimt) or a bovine-derived xenograft (Bio-Osst) in combination with a collagen membrane (Bio-Gidet). A case series</article-title>
<source>J Clin Periodontol</source>
<year>2006</year>
<volume>33</volume>
<fpage>491</fpage>
<lpage>9</lpage>
</nlm-citation>
</ref>
<ref id="ref27">
<label>27</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwarz</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Sculean</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bieling</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ferrari</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Rothamel</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Becker</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Two year clinical results following treatment of peri-implantitis lesions using a nanocristalline hydroxyapatite or a natural bone mineral in combination with a collagen membrane</article-title>
<source>J Clin Periodontol</source>
<year>2008</year>
<volume>35</volume>
<fpage>80</fpage>
<lpage>7</lpage>
</nlm-citation>
</ref>
<ref id="ref28">
<label>28</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goldman</surname>
<given-names>MJ</given-names>
</name>
</person-group>
<article-title>Bone regeneration around an ailing implant using guided bone regeneration. A case report</article-title>
<source>J Periodontol</source>
<year>1992</year>
<volume>63</volume>
<fpage>473</fpage>
<lpage>6</lpage>
</nlm-citation>
</ref>
</ref-list>
<fn-group>
<fn fn-type="supported-by">
<p><bold>Source of Support:</bold> Nil.</p>
</fn>
<fn fn-type="conflict">
<p><bold>Conflict of Interest:</bold> None declared.</p>
</fn>
</fn-group>
</back>
</article>

